S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
The 3-Stock Retirement Blueprint (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
The 3-Stock Retirement Blueprint (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
India launches 5G services, Modi calls it step in new era
The 3-Stock Retirement Blueprint (Ad)
Hong Kong leader promises revival on China's National Day
UK train strikes and energy hikes add to a week of turmoil
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
The 3-Stock Retirement Blueprint (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
The 3-Stock Retirement Blueprint (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
India launches 5G services, Modi calls it step in new era
The 3-Stock Retirement Blueprint (Ad)
Hong Kong leader promises revival on China's National Day
UK train strikes and energy hikes add to a week of turmoil
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
The 3-Stock Retirement Blueprint (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
The 3-Stock Retirement Blueprint (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
India launches 5G services, Modi calls it step in new era
The 3-Stock Retirement Blueprint (Ad)
Hong Kong leader promises revival on China's National Day
UK train strikes and energy hikes add to a week of turmoil
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
The 3-Stock Retirement Blueprint (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
The 3-Stock Retirement Blueprint (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
India launches 5G services, Modi calls it step in new era
The 3-Stock Retirement Blueprint (Ad)
Hong Kong leader promises revival on China's National Day
UK train strikes and energy hikes add to a week of turmoil
NASDAQ:ANGO

AngioDynamics - ANGO Stock Forecast, Price & News

$20.46
-0.11 (-0.53%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$20.44
$21.48
50-Day Range
$19.86
$24.30
52-Week Range
$17.56
$32.00
Volume
230,142 shs
Average Volume
135,192 shs
Market Capitalization
$800.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$31.00

AngioDynamics MarketRank™ Forecast

Analyst Rating
Strong Buy
4.00 Rating Score
Upside/​Downside
51.5% Upside
$31.00 Price Target
Short Interest
Bearish
3.45% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.93
Upright™ Environmental Score
News Sentiment
0.50mentions of AngioDynamics in the last 14 days
Based on 9 Articles This Week
Insider Trading
Selling Shares
$112,200 Sold Last Quarter
Proj. Earnings Growth
533.33%
From $0.03 to $0.19 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.09 out of 5 stars

Medical Sector

612th out of 1,093 stocks

Surgical & Medical Instruments Industry

65th out of 106 stocks

ANGO stock logo

About AngioDynamics (NASDAQ:ANGO) Stock

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

Receive ANGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AngioDynamics and its competitors with MarketBeat's FREE daily newsletter.

ANGO Stock News Headlines

See More Headlines
Receive ANGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AngioDynamics and its competitors with MarketBeat's FREE daily newsletter.

ANGO Company Calendar

Last Earnings
7/12/2022
Today
10/01/2022
Next Earnings (Confirmed)
10/06/2022
Fiscal Year End
5/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:ANGO
CUSIP
03475V10
Employees
800
Year Founded
1988

Price Target and Rating

Average Stock Price Forecast
$31.00
High Stock Price Forecast
$35.00
Low Stock Price Forecast
$27.00
Forecasted Upside/Downside
+51.5%
Consensus Rating
Strong Buy
Rating Score (0-4)
4.00
Research Coverage
1 Analysts

Profitability

Net Income
$-26,550,000.00
Pretax Margin
-9.47%

Debt

Sales & Book Value

Annual Sales
$316.22 million
Cash Flow
$0.75 per share
Book Value
$10.96 per share

Miscellaneous

Free Float
37,192,000
Market Cap
$800.19 million
Optionable
Optionable
Beta
0.90

Social Links


Key Executives

  • Mr. James C. ClemmerMr. James C. Clemmer (Age 58)
    CEO, Pres & Director
    Comp: $1.91M
  • Mr. Stephen A. TrowbridgeMr. Stephen A. Trowbridge (Age 48)
    Exec. VP & CFO
    Comp: $812.99k
  • Mr. David D. HelselMr. David D. Helsel (Age 58)
    Sr. VP of Global Operations and R&D
    Comp: $664.29k
  • Mr. Chad T. Campbell (Age 51)
    Sr. VP & GM of Vascular Access Global Bus. Unit
    Comp: $589.75k
  • Mr. Warren G. Nighan (Age 53)
    Sr. VP of Quality & Regulatory Affairs
    Comp: $622.11k
  • Mr. Richard C. Rosenzweig (Age 55)
    Sr. VP, Gen. Counsel & Company Sec.
  • Mr. Benjamin H. Davis (Age 58)
    Sr. VP of Bus. Devel.
  • Ms. Marna I. Bronfen-Moore (Age 55)
    Sr. VP of HR
  • Ms. Kim L. Seabury (Age 55)
    Sr. VP of Information Technology
  • Mr. Scott CenteaMr. Scott Centea (Age 43)
    Sr. VP & GM of Endovascular Therapies













ANGO Stock - Frequently Asked Questions

Should I buy or sell AngioDynamics stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AngioDynamics in the last twelve months. There are currently 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "strong buy" ANGO shares.
View ANGO analyst ratings
or view top-rated stocks.

What is AngioDynamics' stock price forecast for 2022?

1 brokers have issued 12 month target prices for AngioDynamics' shares. Their ANGO share price forecasts range from $27.00 to $35.00. On average, they expect the company's stock price to reach $31.00 in the next year. This suggests a possible upside of 51.5% from the stock's current price.
View analysts price targets for ANGO
or view top-rated stocks among Wall Street analysts.

How have ANGO shares performed in 2022?

AngioDynamics' stock was trading at $27.58 at the beginning of 2022. Since then, ANGO stock has decreased by 25.8% and is now trading at $20.46.
View the best growth stocks for 2022 here
.

When is AngioDynamics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 6th 2022.
View our ANGO earnings forecast
.

How can I listen to AngioDynamics' earnings call?

AngioDynamics will be holding an earnings conference call on Thursday, October 6th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13732702".

How were AngioDynamics' earnings last quarter?

AngioDynamics, Inc. (NASDAQ:ANGO) released its quarterly earnings results on Tuesday, July, 12th. The medical instruments supplier reported $0.01 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.01. The medical instruments supplier had revenue of $87 million for the quarter, compared to analyst estimates of $82.91 million. AngioDynamics had a negative net margin of 8.40% and a negative trailing twelve-month return on equity of 0.04%. The business's revenue was up 13.3% compared to the same quarter last year.

What guidance has AngioDynamics issued on next quarter's earnings?

AngioDynamics issued an update on its FY 2023 earnings guidance on Tuesday, August, 2nd. The company provided earnings per share guidance of $0.01-$0.06 for the period, compared to the consensus earnings per share estimate of $0.08. The company issued revenue guidance of $342.00 million-$348.00 million, compared to the consensus revenue estimate of $337.70 million.

What is James C. Clemmer's approval rating as AngioDynamics' CEO?

34 employees have rated AngioDynamics Chief Executive Officer James C. Clemmer on Glassdoor.com. James C. Clemmer has an approval rating of 50% among the company's employees. This puts James C. Clemmer in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 47.0% of employees surveyed would recommend working at AngioDynamics to a friend.

What other stocks do shareholders of AngioDynamics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AngioDynamics investors own include General Electric (GE), Intel (INTC), Oasis Petroleum (OAS), Advanced Micro Devices (AMD), Freeport-McMoRan (FCX), Amicus Therapeutics (FOLD), Rigel Pharmaceuticals (RIGL), Accuray (ARAY), Celldex Therapeutics (CLDX) and Chimerix (CMRX).

What is AngioDynamics' stock symbol?

AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO."

How do I buy shares of AngioDynamics?

Shares of ANGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AngioDynamics' stock price today?

One share of ANGO stock can currently be purchased for approximately $20.46.

How much money does AngioDynamics make?

AngioDynamics (NASDAQ:ANGO) has a market capitalization of $800.19 million and generates $316.22 million in revenue each year. The medical instruments supplier earns $-26,550,000.00 in net income (profit) each year or ($0.68) on an earnings per share basis.

How many employees does AngioDynamics have?

The company employs 800 workers across the globe.

Does AngioDynamics have any subsidiaries?
The following companies are subsidiares of AngioDynamics: AngioDynamics Canada Inc., AngioDynamics France SARL, AngioDynamics Medical Brasil Participacoes Ltda., AngioDynamics Netherlands B. V., AngioDynamics UK Limited, AngioDynamics VA LLC, Clinical Devices, Eximo Medical Ltd., FlowMedica, NM Holding Company Inc., Navilyst Medical Holdings Inc., Navilyst Medical Inc., Oncovionic, RITA Medical Systems, RITA Medical Systems LLC, RadiaDyne LLC, and Vortex Medical.
Read More
How can I contact AngioDynamics?

AngioDynamics' mailing address is 14 PLAZA DRIVE, LATHAM NY, 12110. The official website for the company is www.angiodynamics.com. The medical instruments supplier can be reached via phone at (518) 795-1400, via email at mpolyviou@evcgroup.com, or via fax at 518-795-1401.

This page (NASDAQ:ANGO) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.